Treatment of typical Charles Bonnet syndrome with donepezil

International Clinical Psychopharmacology

Volumn 19, Issue 6, 2004, Pages 355-357

  Ukai, Satoshi ^a   Yamamoto, Masakiyo ^a   Tanaka, Michio ^b   Takeda, Masatoshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tanaka Clinic   (Japan)

Author keywords

Charles Bonnet syndrome; Donepezil; Pharmacotherapy; Visual hallucinations

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CHOLINESTERASE INHIBITOR; CLOBAZAM; CLONAZEPAM; DONEPEZIL; FLURAZEPAM; MILNACIPRAN; NEUROLEPTIC AGENT; PROMETHAZINE; TECIPTILINE; VALPROIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CHARLES BONNET SYNDROME; CHOLINERGIC NERVE CELL; COGNITIVE DEFECT; DELIRIUM; DEMENTIA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LEWY BODY; MENTAL DISEASE; PRIORITY JOURNAL; SIDE EFFECT; SLEEP DISORDER; VISUAL HALLUCINATION;

AGED; CHOLINESTERASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALLUCINATIONS; HUMANS; INDANS; PIPERIDINES; VISION DISORDERS;

EID: 8644252083     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200411000-00008     Document Type: Article

References (17)

1. Aarsland D, Bronnick K, Karlsen K (1999). Donepezil for dementia with Lewy bodies: a case study. Int J Geriatr Psychiatry 14:69-72.
2. Batra A, Bartels M, Wormstall H (1997). Therapeutic options in Charles Bonnet syndrome. Acta Psychiatr Scand 96:129-133.
3. Bhatia MS, Khastgir U, Malic SC (1992). Charles Bonnet syndrome. Br J Psychiatry 161:409-410.
4. Cummings JL, Gorman DG, Shapira J (1993). Physostigmine ameliorates the delusions of Alzheimer's disease. Biol Psychiatry 33:536-541.
5. de Morsier G (1936). Les automatismes visuals. Hallucinations rétrochiasmatiques. Schweiz Med Wochenschr 66:700-708.
6. de Morsier G (1967). Le Syndrome de Charles Bonnet: hallucinations visuelles des viellards sans deficience mentale. Ann Med Psychol 125: 677-702.
7. Hori H, Terao T, Shiraishi Y, Nakamura J (2000). Treatment of Charles Bonnet syndrome with valproate. Int Clin Psychopharmacol 15:117-119.
8. Hosty G (1990). Charles Bonnet syndrome: a description of two cases. Acta Psychiatr Scand 82:316-317.
9. Howard R, Meehan O, Powell R, Meilers J (1994). Successful treatment of Charles Bonnet Syndrome type visual hallucinosis with low-dose risperidone. Int J Geriatr Psychiatry 9:677-678.
10. Kornreich C, Dan B, Verbanck P, Pelc I (2000). Treating Charles Bonnet syndrome: understanding inconsistency. J Clin Psychopharmacol 20:396.
11. Menon GJ, Rahman M, Menon SJ, Dutton GN (2003). Complex visual hallucinations in the visually impaired: The Charles Bonnet syndrome. Surv Ophthalmol 48:58-72.
12. Paulig M, Mentrup H (2001). Charles Bonnet's syndrome: complete remission of complex visual hallucinations treated by gabapentin. J Neurol Neurosurg Psychiatry 70:813-814.
13. Pliskin NH, Kiolbasa TA, Towle VL, Pankow L, Ernest JT, Noronha A, et al. (1996). Charles Bonnet Syndrome: An early marker for dementia? J Am Geriatr Soc 44:1055-1061.
14. Terao T (1998). Effect of carbamazepine and clonazepam combination on Charles Bonnet Syndrome: a case report. Hum Psychopharmacol Clin Exp 13:451-453.
15. Terao T (2002). The present state of Charles Bonnet Syndrome. Psychogeriatrics 2:6-14.
16. Terao T, Collinson S (2000). Charles Bonnet syndrome and dementia. Lancet 355:2168.
17. Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG (1996). Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 347:794-797.